The American Pharmacists Association (APhA) cautions pharmacists and the public to be wary of fraudulent COVID-19 products and scams being offered online or through other channels during the pandemic. Read More »

Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials showed inclisiran reduced low-density lipoprotein-cholesterol (LDL-C) by 51% at 17 months Read More »

The Synthetic Biology Leader Steps Out to Help Fight COVID-19 Read More »

UCSF Health, Northwell Health, UNC Health and other systems using Conversa's virtual care and communication platform to triage people in their communities, manage patients, and screen healthcare workers Read More »

Leading health tech company is the first to introduce novel approach to addressing the COVID-19 pandemic Read More »

The American Pharmacists Association (APhA) recommends that patients and/or caregivers ensure that they have adequate supplies of necessary medications to address their needs if not able to get to the pharmacy because of coronavirus. Read More »

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement with Brigham and Women's Hospital for an investigator-initiated study led by Richard D. Urman MD, MBA, Associate Professor of Anesthesia and co-director of the Center for Perioperative Research at Brigham and Women's Hospital and Harvard Medical School. Read More »

The American Pharmacists Association (APhA) submitted comments to the Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ) Antitrust Division addressing the impact vertical mergers are having on the pharmacy supply chain, medication pricing and patient access and choice. Read More »

FDA-approved GLOPERBA (colchicine) is now available in pharmacies Read More »

The educational sessions are available live and via simulcast Read More »

Healthcare Technology Company Becomes Organization’s Provider of Enterprise Solutions for Pharmacy Benefits Administration Read More »

As healthcare costs continue to rise in 2020, Valpak, a leader in local print and digital marketing, recently announced a new way to help their customers save on prescription drugs: ValpakRx. Read More »

MakoRx's new disruptive pharmacy subscription model provides access to over 300 medications for free Read More »

Best in Class Ingredients from Diamond Dust to Caviar, Retinol to The Most Bioavailable Oil-Soluble Vitamin C Read More »

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that Anthem Biosciences of Bangalore, India (Anthem) has completed a pilot run of the recrystallization of the Reata Pharmaceuticals, Inc. API (Reata). Read More »

PharmaMar and Jazz signed an exclusive license agreement on 19 December 2019 for lurbinectedin in the United States Read More »

DisposeRx, Inc., manufacturer of the market leading at-home medication disposal solution, has in place a network of more than 1,000 pharmacies in New Jersey ready to meet the requirements of new legislation signed into law today. Read More »

Loopback Analytics, a leading provider of data-driven solutions for hospital and health systems, announced today they are working with UF Health Jacksonville to help advance specialty pharmacy services. Read More »

Partnership designed to make essential compounded sterile products for CADD® infusion pumps more widely available Read More »

Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a new chemical drug for the treatment of major depressive disorder. It is also the second U.S. FDA NDA submission in the central nervous system (CNS) filed by the company. Read More »